lsy-23

Caenorhabditis elegans

emb-23

Caenorhabditis elegans

F40F12.10

Caenorhabditis elegans

Is affected by wdr-23 based on RNA-seq studies.

sup-23

Caenorhabditis elegans

nlp-23

Caenorhabditis elegans

Predicted to be involved in neuropeptide signaling pathway. Expressed in hypodermis and tail.

rad-23

Caenorhabditis elegans

Predicted to enable polyubiquitin modification-dependent protein binding activity; proteasome binding activity; and ubiquitin binding activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol and nucleoplasm. Expressed in dorsal nerve cord; head; neurons; ventral nerve cord; and vulva. Is an ortholog of human RAD23A (RAD23 homolog A, nucleotide excision repair protein).

srj-12

Caenorhabditis elegans

Is affected by clk-1 and wdr-23 based on microarray and RNA-seq studies.

Y50D4B.8

Caenorhabditis elegans

Is affected by daf-2 and wdr-23 based on microarray and RNA-seq studies.

glb-23

Caenorhabditis elegans

Predicted to enable heme binding activity; oxygen binding activity; and oxygen carrier activity. Predicted to be involved in oxygen transport. Expressed in head neurons; lateral nerve cord; ventral cord neurons; and ventral nerve cord.

str-53

Caenorhabditis elegans

Is affected by wdr-23 and let-60 based on RNA-seq and microarray studies.